A detailed history of Fountainhead Am, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Fountainhead Am, LLC holds 2,450 shares of JNJ stock, worth $379,774. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,450
Previous 2,516 2.62%
Holding current value
$379,774
Previous $367,000 8.17%
% of portfolio
0.09%
Previous 0.09%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$145.48 - $167.38 $9,601 - $11,047
-66 Reduced 2.62%
2,450 $397,000
Q2 2024

Jul 26, 2024

BUY
$144.38 - $157.78 $20,213 - $22,089
140 Added 5.89%
2,516 $367,000
Q1 2024

Apr 30, 2024

BUY
$155.22 - $162.74 $25,145 - $26,363
162 Added 7.32%
2,376 $375,000
Q4 2023

Feb 01, 2024

BUY
$145.6 - $158.88 $3,494 - $3,813
24 Added 1.1%
2,214 $347,000
Q3 2023

Nov 01, 2023

BUY
$155.75 - $174.48 $5,918 - $6,630
38 Added 1.77%
2,190 $341,000
Q2 2023

Aug 02, 2023

BUY
$154.35 - $166.11 $14,817 - $15,946
96 Added 4.67%
2,152 $356,000
Q1 2023

May 12, 2023

SELL
$151.05 - $180.26 $8,911 - $10,635
-59 Reduced 2.79%
2,056 $318,000
Q4 2022

Feb 09, 2023

BUY
$160.2 - $179.79 $20,025 - $22,473
125 Added 6.28%
2,115 $373,000
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $1,613 - $1,795
10 Added 0.51%
1,990 $325,000
Q2 2022

Aug 08, 2022

BUY
$168.19 - $186.01 $5,213 - $5,766
31 Added 1.59%
1,980 $351,000
Q1 2022

May 06, 2022

SELL
$158.14 - $179.59 $10,753 - $12,212
-68 Reduced 3.37%
1,949 $345,000
Q4 2021

Feb 03, 2022

BUY
$155.93 - $173.01 $467 - $519
3 Added 0.15%
2,017 $345,000
Q3 2021

Oct 29, 2021

SELL
$161.5 - $179.47 $3,876 - $4,307
-24 Reduced 1.18%
2,014 $325,000
Q1 2021

May 06, 2021

SELL
$153.07 - $170.48 $20,052 - $22,332
-131 Reduced 6.04%
2,038 $335,000
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $297,391 - $341,357
2,169 New
2,169 $341,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Fountainhead Am, LLC Portfolio

Follow Fountainhead Am, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fountainhead Am, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fountainhead Am, LLC with notifications on news.